SI
MRK icon

Sava Infond’s Merck MRK Stock Holding History

Sava Infond’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
88,000
+34,380
+64% +$4.02M 0.8% 27
2026
Q1 		$6.45M Buy
53,620
+11,930
+29% +$1.38M 0.92% 25
2025
Q4 		$4.39M Buy
41,690
+1,120
+3% +$105K 0.59% 33
2025
Q3 		$3.41M Hold
40,570
– – 0.48% 38
2025
Q2 		$3.21M Buy
40,570
+5,700
+16% +$453K 0.5% 38
2025
Q1 		$3.13M Buy
34,870
+4,000
+13% +$373K 0.6% 38
2024
Q4 		$3.07M Buy
+30,870
New +$3.18M 0.54% 38

Other funds holding MRK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Sava Infond's MRK Position: Q2 2026 in Review

Sava Infond increased its Merck (MRK) stake by 64% in Q2 2026, buying an estimated $4.02M and bringing the position to 88,000 shares worth $11.3M. The position accounts for 0.8% of the portfolio, ranked #27.

Sava Infond first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 2,371 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sava Infond held 88,000 shares of Merck worth $11.3M as of Q2 2026.
  • Sava Infond bought 34,380 Merck shares in Q2 2026, an estimated $4.02M.
  • Merck made up 0.8% of Sava Infond's portfolio in Q2 2026, its #27 holding.
  • Sava Infond first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 2,371 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.